Clinical Observation On Treatment Of Ischemic Stroke With Qi - Deficiency And Blood - Stasis Syndrome By

Purpose:By observing the therapeutic effect and safety of using Naoshuantong decoction to treat patients suffering from acute ischemic stroke with qi deficiency and blood stasis, it highlights the advantages for the use of traditional Chinese medicine to treat relevant diseases, which is of great significance for the increasing of its clinical curative effect and the expansion of its scope of intervention.Material and method:60 cases of hospitalized patients (receive d by Encephalopathy Department I of the Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine from September 2 013 to December 2014), who are suffering from acute ischemic stroke, an apoplexy involving the channels and collaterals with qi deficiency and blood stasis by syndrome differentiation, are selected. Then div ide them equally into treatment group and control group following the randomized control trial. The two groups are then given basic treatme nt for 14 days in accordance the 《Prevention and Control Guidelines for Cerebrovascular Diseases in China》. In addition to the same basi c treatment, the treatment group are also orally administered with Na oshuantong decoction for a consecutive 28 days (Formulation:astragal us membranaceus 30g, Ligusticum wallichii 15g, pseudo-ginseng 5g, roo t of common peony 15g, earthworm 15g and so on, decocted with water and take 100 ml of extracted liquid each time for a total of 3 times per day). Two groups of patients with Stable condition in accordance the 《Prevention and Control Guidelines for Cerebrovascular Diseases in China to rehabilitation》. Record the TCM syndromes and SNFD for th e two groups of patients at 14 days before and after the treatment, a nd at 28 days after the treatment. Record modified Rankin Scale score s and ADL (Barthel indicators) scores for the two groups of patients at 28 days before and after the treatment, and at 90 days after the o nset of such disease.Results:1. The TCM syndromes scores for the treatment group and control group between before and after the treatment are all significant (P<0.05). However, the improvement of treatment group is higher than that of control group (P<0.05). The treatment group is better than control group in the curative effect (P<0.05).2.The NIHSS for the treatment group and control group between before and after the treatment are all significant (P<0.05). However, the improvement of treatment group is higher than that of control group (P<0.05). The treatment group is better than control group in the curative effect (P<0.05).3. Both groups have significant differences in terms of the modified Rankin Scale scores and ADL (Barthel indicators) scores between before the treatment and 90 days after the onset of such disease (P<0.05). However, the improvement of treatment group is higher than that of control group (P<0.05). The treatment group is better than control group in the number of life is relatively independent.4. No adverse reaction is found on both groups of patients during medication. Hence no patient discontinues the treatment due to serious case of adverse reaction.Conclusion:Naoshuantong decoction can significantly improve the clinical symptoms of patients suffering from ischemic stroke. It facilitates the recovery of neurological function and improves the living quality and long term prognosis of the patients. With its safety in use, it is worth the promotion of its clinical use.